Rhythm Biosciences

Rhythm Biosciences, located in Melbourne, Victoria, is pioneering innovative technologies for cancer diagnostics, focusing on early detection to improve patient outcomes. Their flagship product, ColoSTAT, is a blood-based test aimed at revolutionizing colorectal cancer screening, complemented by the geneType platform for personalized risk assessment across various cancer types.

Committed to scientific innovation and accessible testing solutions, Rhythm Biosciences aims to reduce healthcare costs while enhancing the management and treatment of diseases. The company is rapidly expanding its product portfolio to offer high-quality solutions backed by robust scientific, clinical, and economic evidence.

Generated from the website